Cholesterol Metabolism Is Potential Therapeutic Target in DMD

Cholesterol Metabolism Is Potential Therapeutic Target in DMD

296666

Cholesterol Metabolism Is Potential Therapeutic Target in DMD

An analysis of microRNA molecules isolated from the blood of people with Duchenne muscular dystrophy (DMD) found alterations related to cholesterol metabolism, a study demonstrated. These findings suggest that the cholesterol metabolic pathway may be a potential therapeutic target for this most common type of muscular dystrophy, the scientists said. “The present study provides new understanding of the metabolic [deviations] in DMD and thus opens up new perspectives for the treatment of DMD,” the researchers…

You must be logged in to read/download the full post.